FDA
approval
· 2023-08-25
FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (SpecGx LLC)
Summary
FDA approved lisdexamfetamine dimesylate under an Original Application (generic) filed by SpecGx LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)